Of the 23 patients who achieved ycN0 by AUS and breast cCR by MRI, we found that the accurate prediction rate of ypN0 was 100% in patients with HR±/HER2+ or HR−/HER2− breast cancer, and only 57% in HR+ /HER2− breast cancer. This evidence concerns the gene ERBB2 and breast cancer.